AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,933,000 | -42.2% | 843,940 | -27.5% | 1.12% | -28.7% |
Q2 2020 | $17,186,000 | +9.3% | 1,164,343 | 0.0% | 1.56% | -45.7% |
Q1 2020 | $15,719,000 | -46.9% | 1,164,343 | -4.9% | 2.88% | -35.5% |
Q4 2019 | $29,604,000 | +52.4% | 1,224,825 | +21.2% | 4.46% | +94.4% |
Q3 2019 | $19,422,000 | +414.6% | 1,010,488 | +910.5% | 2.29% | +1226.0% |
Q3 2016 | $3,774,000 | – | 100,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |